3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Pediatric Cancer Patients
1
Pancreatic Neoplasms
1
Head and Neck Neoplasms
1
Chondrosarcoma
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Doxorubicin
3
spartalizumab
1
nilotinib
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
envafolimab
1
Trabectedin
1
TQ-B3525
1
Radiotherapy
1
Proton Therapy
1
Nivolumab
1
Neoadjuvant Therapy
1
Ipilimumab
1
Immune Checkpoint Inhibitors
1
Ifosfamide
1
Heavy Ion Radiotherapy
1
Gelclair
1
Chemotherapy, Adjuvant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Chondrosarcoma
×
Proton Therapy
×
Clear all
NCT01182753
2010-08-17
CSP12C
Heidelberg University
Phase 3
Unknown
154 enrolled